About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth

AH_2025Q2_PipelineDigest_063025.2 3

BERWYN, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the release of its Q2 2025 Specialty & Rare Pipeline Digest™. As the industry’s most comprehensive digital resource, this complimentary quarterly publication provides stakeholders with critical, up-to-date information on new, pending and upcoming specialty and rare disease drug launches and approvals, biosimilars and cell and gene therapies (CGTs). Designed to support stakeholders amid the accelerating pace of specialty drug approvals, the Digest delivers timely insights that enable proactive management and strategic utilization of emerging therapies.

"The continued acceleration of specialty and rare drug development – with over a dozen new approvals in Q2 alone – highlights the critical need for a comprehensive resource that helps industry stakeholders stay ahead of evolving market dynamics,” says Andy Szczotka, PharmD, chief pharmacy officer, AscellaHealth. “Our dedicated team of clinical researchers and expert data analysts meticulously develops this robust digest to provide manufacturers, payers and providers with actionable intelligence that supports strategic decision-making and, ultimately, enhances patient outcomes.”

Q2 2025 Highlights: Growth in Specialty and CGT Approvals
The second quarter of 2025 witnessed an uptick in the volume of newly approved branded specialty medications, reflecting the FDA’s ongoing commitment to expediting access to therapies for complex diseases. Among these, CGTs continue to demonstrate strong momentum, with Q2 marking several important milestones in the treatment of rare and serious conditions. Both recent approvals and therapies under regulatory review highlight the expanding potential of CGTs to transform care and improve outcomes for patients with limited treatment options.

Looking Ahead: 2025–2026 Outlook
The specialty drug pipeline is projected to experience steady growth through 2026, with a continued emphasis on orphan drugs and CGTs. Specialty medications are expected to account for more than half of total drug spending during this period, reflecting their increasing role in addressing complex conditions. Currently, 71% of new drug submissions are classified as specialty, and 34% carry orphan drug designation—highlighting the industry’s sustained focus on delivering innovative treatments for underserved patient populations.

Read more findings in the latest Specialty & Rare Pipeline Digest™ here.

About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. For more information on our services and solutions, visit www.AscellaHealth.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/da3fd58d-acbe-4e8e-a2a2-c42a0ace8c2d

This press release was published by a CLEAR® Verified individual.


Media:

Caroline Chambers
CPR Communications
cchambers@cpronline.com
201.641.1911 x 21

Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
+0.00 (0.00%)
AAPL  252.29
+0.00 (0.00%)
AMD  233.08
+0.00 (0.00%)
BAC  51.28
+0.00 (0.00%)
GOOG  253.79
+0.00 (0.00%)
META  716.91
+0.00 (0.00%)
MSFT  513.58
+0.00 (0.00%)
NVDA  183.16
-0.06 (-0.03%)
ORCL  291.31
+0.00 (0.00%)
TSLA  439.31
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.